Daniel F. Voytas, Chief Science Officer at Calyxt, Inc. (CLXT), sold 2,513 shares at $4.13 ($10K) on 2021-01-04, disclosed to the SEC on 2021-01-05.
Scheduled sale ($10k) by Chief Science Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CLXT | SELL | 2019-02-26 | $64K | — | Filing → |
| CLXT | SELL | 2019-02-04 | $106K | — | Filing → |
| CLXT | SELL | 2018-12-20 | $53K | — | Filing → |